1,479
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Long-term improvement of symptoms of angina pectoris after successful revascularization of coronary artery chronic total occlusions

, , , &
Article: 2161621 | Received 12 Sep 2022, Accepted 17 Dec 2022, Published online: 01 Jan 2023

References

  • Di Mario C, Werner GS, Sianos G, et al. European perspective in the recanalisation of chronic total occlusions (CTO): consensus document from the EuroCTO club. EuroIntervention. 2007;3(1):30–43.
  • Galassi AR, Werner GS, Boukhris M, et al. Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO club. EuroIntervention. 2019;15(2):198–208.
  • Sianos G, Werner GS, Galassi AR, et al. Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club. EuroIntervention. 2012;8(1):139–145.
  • Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018;39(26):2484–2493.
  • Lee SW, Lee PH, Ahn JM, et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion. Circulation. 2019;139(14):1674–1683.
  • Sapontis J, Salisbury AC, Yeh RW, et al. Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO registry (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures). JACC Cardiovasc Interv. 2017;10(15):1523–1534.
  • Hirai T, Grantham JA, Sapontis J, et al. Quality of life changes after chronic total occlusion angioplasty in patients with baseline refractory angina. Circ Cardiovasc Interv. 2019;12(3):e007558.
  • Grantham JA, Jones PG, Cannon L, et al. Quantifying the early health status benefits of successful chronic total occlusion recanalization: results from the FlowCardia’s approach to chronic total occlusion recanalization (FACTOR) trial. Circ Cardiovasc Qual Outcomes. 2010;3(3):284–290.
  • Qintar M, Grantham JA, Sapontis J, et al. Dyspnea among patients with chronic total occlusions undergoing percutaneous coronary intervention: prevalence and predictors of improvement. Circ Cardiovasc Qual Outcomes. 2017;10(12):e003665.
  • Ybarra LF, Rinfret S, Brilakis ES, et al. Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC consensus recommendations. Circulation. 2021;143(5):479–500.
  • Abuzeid W, Zivkovic N, Elbaz-Greener G, et al. Association between revascularization and quality of life in patients with coronary chronic total occlusions: a systematic review. Cardiovasc Revasc Med. 2021;25:47–54.
  • Christakopoulos GE, Christopoulos G, Carlino M, et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol. 2015;115(10):1367–1375.
  • van Veelen A, Elias J, van Dongen IM, et al. Percutaneous coronary intervention versus medical therapy for chronic total coronary occlusions: a systematic review and meta-analysis of randomised trials. Neth Heart J. 2021;29(1):30–41.
  • Obedinskiy AA, Kretov EI, Boukhris M, et al. The IMPACTOR-CTO trial. JACC Cardiovasc Interv. 2018;11(13):1309–1311.
  • Jaguszewski M, Targonski R, Fijalkowski M, et al. Recanalization of isolated chronic total occlusions in patients with stable angina. Int J Cardiol. 2013;167(4):1542–1546.
  • McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24(1):4–131.
  • Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–e1032.
  • Perera D, Clayton T, O'Kane PD, et al. Percutaneous revascularization for ischemic left ventricular dysfunction. N Engl J Med. 2022;387(15):1351–1360.
  • Patel VG, Brayton KM, Tamayo A, et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv. 2013;6(2):128–136.
  • Brilakis ES, Banerjee S, Karmpaliotis D, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2015;8(2):245–253.
  • Othman H, Seth M, Zein R, et al. Percutaneous coronary intervention for chronic total occlusion-the Michigan experience: insights from the BMC2 registry. JACC Cardiovasc Interv. 2020;13(11):1357–1368.
  • Young MN, Secemsky EA, Kaltenbach LA, et al. Examining the operator learning curve for percutaneous coronary intervention of chronic total occlusions. Circ Cardiovasc Interv. 2019;12(8):e007877.
  • Christopoulos G, Menon RV, Karmpaliotis D, et al. The efficacy and safety of the "hybrid" approach to coronary chronic total occlusions: insights from a contemporary multicenter US registry and comparison with prior studies. J Invasive Cardiol. 2014;26(9):427–432.
  • Khan MF, Brilakis ES, Wendel CS, et al. Comparison of procedural complications and in-hospital clinical outcomes between patients with successful and failed percutaneous intervention of coronary chronic total occlusions: a meta-analysis of observational studies. Catheter Cardiovasc Interv. 2015;85(5):781–794.
  • Jones DA, Weerackody R, Rathod K, et al. Successful recanalization of chronic total occlusions is associated with improved long-term survival. JACC Cardiovasc Interv. 2012;5(4):380–388.
  • Jaguszewski M, Ciecwierz D, Gilis-Malinowska N, et al. Successful versus unsuccessful antegrade recanalization of single chronic coronary occlusion: eight-year experience and outcomes by a propensity score ascertainment. Catheter Cardiovasc Interv. 2015;86(2):E49–E57.
  • Hoebers LP, Claessen BE, Elias J, et al. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. Int J Cardiol. 2015;187:90–96.
  • Megaly M, Saad M, Tajti P, et al. Meta-analysis of the impact of successful chronic total occlusion percutaneous coronary intervention on left ventricular systolic function and reverse remodeling. J Interv Cardiol. 2018;31(5):562–571.
  • Elias J, van Dongen IM, Råmunddal T, et al. Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction. Heart. 2018;104(17):1432–1438.
  • Juricic SA, Tesic MB, Galassi AR, et al. Randomized controlled comparison of optimal medical therapy with percutaneous recanalization of chronic total occlusion (COMET-CTO). Int Heart J. 2021;62(1):16–22.